Related Experiment Video

Updated: Aug 10, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

[Mechanical cardiac assistance and artificial heart: historical perspectives]

E Flecher1, T Joudinaud, J-M Grinda

  • 1Service de chirurgie cardiovasculaire, hôpital européen Georges-Pompidou, 20-40, rue Leblanc, 75015 Paris, France. erwan.flecher@wanadoo.fr

Annales De Chirurgie
|March 15, 2006
PubMed

Insights

Artificial hearts offer a lifeline for end-stage heart failure patients awaiting transplants. These devices restore circulation, enabling patients to await transplantation at home, easing the donor organ shortage.

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering
  • Medical Devices

Context:

  • Growing impact of heart failure on patients and healthcare systems.
  • Cardiac transplantation remains the primary treatment for end-stage heart failure.
  • Shortage of donor organs and long waiting lists for cardiac transplantation.

Purpose:

  • To review the development and application of artificial hearts.
  • To highlight technical advancements in artificial heart technology.
  • To discuss the potential of artificial hearts as destination therapy.

Summary:

  • Artificial hearts (total and partial) were developed due to donor organ scarcity.
  • Technical progress since 1957 allows patients to have circulation restored and await transplantation at home.
  • Encouraging results and device miniaturization suggest artificial hearts as destination therapy for ineligible transplant candidates.

Impact:

  • Provides a viable circulatory support option for end-stage heart failure patients.
  • Addresses the critical shortage of donor hearts for transplantation.
  • Offers potential for improved quality of life and extended survival for patients ineligible for transplantation.

More Related Videos

Implantation of the Syncardia Total Artificial Heart16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...